12 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-10-07NCT05512364
Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderRecruitingNot stated2026-07-16NCT07617610
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLCSCLC,Extensive Stage; SLFN11-positiveRecruitingPhase 22026-05-29NCT05718323
REDUCE LAP-HF III Corvia Protocol 1701cardiovascular disorder, heart disorder, heart failureActive, not recruitingNot stated2026-05-12NCT03191656
Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac SurgeryInfarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderActive, not recruitingNot stated2026-05-05NCT05859620
Impact of Core Muscle Training on Incisional Hernia and Pain After Abdominal SurgeryHernia, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative ComplicationsRecruitingNot applicable2026-05-05NCT03808584
Swiss Cerebral Palsy RegistryBrain Damage, Chronic, brain disorder, central nervous system disorder, cerebral palsy, nervous system disorderRecruitingNot stated2026-02-13NCT04992871
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 WeeksGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder, skin disorderActive, not recruitingPhase 32025-12-30NCT02051218
The Medacta International SMS Post-Marketing Surveillance StudyArthrosis, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hip Dislocation, Congenital, Musculoskeletal Abnormalities, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, avascular necrosis of femoral head, primary, 1, bone disorder, developmental dysplasia of the hip, familial avascular necrosis of femoral head, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorderRecruitingNot stated2025-09-29NCT02748408
Colchicine After Electrocardioversion for Atrial FibrillationArrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorderRecruitingPhase 32025-05-28NCT05890664
Atrial Fibrillation Before and After Patent Foramen Ovale Closure StudyArrhythmias, Cardiac, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorderActive, not recruitingNot stated2025-05-13NCT04881578
Multicentre GMK UNI Anatomical Cementless Study - FRarthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorderActive, not recruitingNot stated2024-12-16NCT06715917